MXPA05011249A - Combinaciones de desoxipeganina y mecamilamina para el tratamiento del abuso de alcohol. - Google Patents
Combinaciones de desoxipeganina y mecamilamina para el tratamiento del abuso de alcohol.Info
- Publication number
- MXPA05011249A MXPA05011249A MXPA05011249A MXPA05011249A MXPA05011249A MX PA05011249 A MXPA05011249 A MX PA05011249A MX PA05011249 A MXPA05011249 A MX PA05011249A MX PA05011249 A MXPA05011249 A MX PA05011249A MX PA05011249 A MXPA05011249 A MX PA05011249A
- Authority
- MX
- Mexico
- Prior art keywords
- desoxypeganine
- mecamylamine
- treatment
- combination
- alcohol abuse
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cephalosporin Compounds (AREA)
Abstract
La invencion se refiere a la combinacion de principios activos, que esta constituida por desoxipeganina o uno de sus derivados aceptables desde el punto de vista farmaceutico y mecamilamina o uno de sus derivados aceptables desde el punto de vista farmaceutico que sirve para la fabricacion de un medicamento para el tratamiento del abuso de alcohol y/o la dependencia del alcohol.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10318714A DE10318714B4 (de) | 2003-04-25 | 2003-04-25 | Wirkstoff-Kombinationen und Therapien zur Bekämpfung des Alkoholmissbrauches |
PCT/EP2004/004033 WO2004096200A1 (de) | 2003-04-25 | 2004-04-16 | Kombination aus desoxypeganin und mecamylamin zur behandlung des alkoholmissbrauches |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA05011249A true MXPA05011249A (es) | 2005-12-14 |
Family
ID=33304936
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA05011249A MXPA05011249A (es) | 2003-04-25 | 2004-04-16 | Combinaciones de desoxipeganina y mecamilamina para el tratamiento del abuso de alcohol. |
Country Status (18)
Country | Link |
---|---|
US (1) | US20060199866A1 (es) |
EP (1) | EP1617831A1 (es) |
JP (1) | JP2006524647A (es) |
KR (1) | KR20060006946A (es) |
CN (1) | CN1771029A (es) |
AR (1) | AR044067A1 (es) |
AU (1) | AU2004233564A1 (es) |
BR (1) | BRPI0410507A (es) |
CA (1) | CA2523331A1 (es) |
CL (1) | CL2004000881A1 (es) |
DE (1) | DE10318714B4 (es) |
EA (1) | EA200501514A1 (es) |
MX (1) | MXPA05011249A (es) |
MY (1) | MY136408A (es) |
NO (1) | NO20054243L (es) |
TW (1) | TW200427452A (es) |
WO (1) | WO2004096200A1 (es) |
ZA (1) | ZA200507213B (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2073813A2 (en) * | 2006-10-10 | 2009-07-01 | The University of Chicago | Composition s comprising a benzodiazepine, an alcohol aversive agent and an abuse aversive agent |
CN108498493A (zh) * | 2017-02-27 | 2018-09-07 | 中国人民解放军第二军医大学 | 美加明防治晕动症或眩晕症的医药用途 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3797494A (en) * | 1969-04-01 | 1974-03-19 | Alza Corp | Bandage for the administration of drug by controlled metering through microporous materials |
US3996934A (en) * | 1971-08-09 | 1976-12-14 | Alza Corporation | Medical bandage |
US3742951A (en) * | 1971-08-09 | 1973-07-03 | Alza Corp | Bandage for controlled release of vasodilators |
US4031894A (en) * | 1975-12-08 | 1977-06-28 | Alza Corporation | Bandage for transdermally administering scopolamine to prevent nausea |
DE3315272C2 (de) * | 1983-04-27 | 1986-03-27 | Lohmann Gmbh & Co Kg, 5450 Neuwied | Pharmazeutisches Produkt und Verfahren zu seiner Herstellung |
US5316759A (en) * | 1986-03-17 | 1994-05-31 | Robert J. Schaap | Agonist-antagonist combination to reduce the use of nicotine and other drugs |
DE3843239C1 (es) * | 1988-12-22 | 1990-02-22 | Lohmann Therapie Syst Lts | |
EP1019088B1 (en) * | 1997-10-03 | 2003-02-12 | Cary Medical Corporation | Composition for the treatment of nicotine addiction containing mecamylamine and bupropion |
PT1139743E (pt) * | 1998-12-16 | 2006-06-30 | Univ South Florida | Formulacao de exo-s-mecamilamina e utilizacao em tratamento |
DE19906974C2 (de) * | 1999-02-19 | 2003-10-09 | Lohmann Therapie Syst Lts | Verwendung von Desoxypeganin zur Behandlung des Alkoholismus |
DE10129265A1 (de) * | 2001-06-18 | 2003-01-02 | Hf Arzneimittelforsch Gmbh | Wirkstoff-Kombination zur medikamentösen Sucht- oder Rauschmitteltherapie |
-
2003
- 2003-04-25 DE DE10318714A patent/DE10318714B4/de not_active Expired - Fee Related
-
2004
- 2004-04-16 MX MXPA05011249A patent/MXPA05011249A/es not_active Application Discontinuation
- 2004-04-16 CN CNA2004800094893A patent/CN1771029A/zh active Pending
- 2004-04-16 KR KR1020057020318A patent/KR20060006946A/ko not_active Application Discontinuation
- 2004-04-16 WO PCT/EP2004/004033 patent/WO2004096200A1/de not_active Application Discontinuation
- 2004-04-16 JP JP2006505158A patent/JP2006524647A/ja active Pending
- 2004-04-16 EP EP04727830A patent/EP1617831A1/de not_active Withdrawn
- 2004-04-16 EA EA200501514A patent/EA200501514A1/ru unknown
- 2004-04-16 CA CA002523331A patent/CA2523331A1/en not_active Abandoned
- 2004-04-16 AU AU2004233564A patent/AU2004233564A1/en not_active Abandoned
- 2004-04-16 US US10/554,350 patent/US20060199866A1/en not_active Abandoned
- 2004-04-16 BR BRPI0410507-9A patent/BRPI0410507A/pt not_active Application Discontinuation
- 2004-04-22 MY MYPI20041476A patent/MY136408A/en unknown
- 2004-04-23 AR ARP040101378A patent/AR044067A1/es unknown
- 2004-04-23 TW TW093111538A patent/TW200427452A/zh unknown
- 2004-04-26 CL CL200400881A patent/CL2004000881A1/es unknown
-
2005
- 2005-09-08 ZA ZA200507213A patent/ZA200507213B/en unknown
- 2005-09-13 NO NO20054243A patent/NO20054243L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2006524647A (ja) | 2006-11-02 |
WO2004096200A1 (de) | 2004-11-11 |
TW200427452A (en) | 2004-12-16 |
NO20054243L (no) | 2005-09-13 |
CN1771029A (zh) | 2006-05-10 |
KR20060006946A (ko) | 2006-01-20 |
AR044067A1 (es) | 2005-08-24 |
ZA200507213B (en) | 2006-05-31 |
CA2523331A1 (en) | 2004-11-11 |
US20060199866A1 (en) | 2006-09-07 |
CL2004000881A1 (es) | 2005-01-21 |
EP1617831A1 (de) | 2006-01-25 |
EA200501514A1 (ru) | 2006-04-28 |
DE10318714B4 (de) | 2006-03-23 |
DE10318714A1 (de) | 2004-11-18 |
BRPI0410507A (pt) | 2006-06-20 |
AU2004233564A1 (en) | 2004-11-11 |
MY136408A (en) | 2008-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0703786T3 (da) | Anvendelse af nona- og dekapeptider til fremstilling af et lægemiddel til behandling af AIDS | |
IL195723A (en) | Use of p53 inhibitors for the preparation of medicament | |
GB0031088D0 (en) | Medicaments | |
GB0118238D0 (en) | Medicaments | |
HUP0203623A2 (hu) | Tramadol-szacharinátot tartalmazó, késleltetett hatású adagolási forma és alkalmazása | |
GB0112836D0 (en) | Medicaments | |
NO993520D0 (no) | Doseringsformer og fremgangsmåte for å bedre erektil dysfunksjon | |
AU2003220317A1 (en) | Methods and drug delivery systems for the treatment of orofacial diseases | |
PL367277A1 (en) | Methods of making sustained release formulations of oxymorphone related applications | |
AU2002236765A1 (en) | Pharmaceutical combination for the treatment of cancer containing a 4-quinazolineamine and another anti-neoplastic agent | |
MXPA05008406A (es) | Compuestos de amida tri(ciclo)-sustituida. | |
AU2002236647A1 (en) | Method and device for administering medication and/or placebo | |
MXPA04005980A (es) | Un metodo y dispositivo para reducir dosificacion terapeutica. | |
AUPR839001A0 (en) | Dosage form, device and methods of treatment | |
AU6528400A (en) | Triple drug therapy for the treatment of narcotic and alcohol withdrawal symptoms | |
AU2002226427A1 (en) | Use of flumazenil in developing a drug for the treatment of alcohol dependence | |
DE60102590T2 (de) | Darreichungsformen zur behandlung von oralen mykosen | |
WO2005039481A3 (en) | Oral drug delivery system | |
IL150289A0 (en) | Drug combination for the treatment of depression and related disorders comprising mirtazapine | |
EP1534295A4 (en) | FORMULATIONS AND METHODS OF ADMINISTRATION OF CEPHALOTAXINS, INCLUDING HOMOHARRINGTONIN | |
DE69941825D1 (de) | Arzneistoffhaltiger kaugummi, dessen herstellungsverfahren und so erhaltene tablette | |
NZ528164A (en) | Use of flumazenil to produce a medicament for the treatment of cocaine dependency | |
IL162768A0 (en) | Method of treatment of a patient requiring analgesia | |
WO2002053149A3 (de) | Arzneimittel enthaltend ein polyamin als wirksubstanz | |
AU2002313364A1 (en) | Use of a compound in providing refreshedness on waking and a method for the treatment of drowsiness therewith |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |